GraftCath Collects $12 Million Series D Round
Thursday, February 21, 2008 5:49:00 AM PDT | VentureDeal staff
Eden Prairie, MN -- Medical device company GraftCath, Inc. has received $12 million in series D venture capital investment, according to a report in PE Hub.
GraftCath is developing femoral vascular closure procedure technologies and medical devices.
Affinity Capital lead the round, which included fellow new investor Ascension Health Ventures and existing investors Cutlass Capital, Sapient Capital and Three Arch Partners.
The company did not disclose how it would use the funding proceeds.
Email Page | Print Page